Skip to main navigation Skip to search Skip to main content

Corrigendum: Big Data and Real-World Data Based Cost-Effectiveness Studies and Decision-Making Models: A Systematic Review and Analysis (Front. Pharmacol., (2021), 12, (700012), 10.3389/fphar.2021.700012)

  • Z. Kevin Lu
  • , Xiaomo Xiong
  • , Taiying Lee
  • , Jun Wu
  • , Jing Yuan
  • , Bin Jiang

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original article, there was an error in the 3rd paragraph in the Discussion section. In this paragraph of the original text, we included the sentence “Furthermore, in long-term CEA studies without the model, most of them were not discounted. Some of these studies even used a life-long time horizon (Armeni et al., 2016; Liao et al., 2017; Wei et al., 2017).” Here, the context may mislead readers that Armeni et al., 2016’s study did not use an analytic model and discount, but in fact, while they used a life-time horizon, their study used an analytic model and discounted the long-term outcomes in the model. Therefore, the citation for Armeni et al., 2016 was removed and the corrected sentence is “Furthermore, in long-term CEA studies without the model, most of them were not discounted. Some of these studies even used a life-long time horizon (Liao et al., 2017; Wei et al., 2017).” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number833827
JournalFrontiers in Pharmacology
Volume12
DOIs
StatePublished - Jan 25 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2022 Lu, Xiong, Lee, Wu, Yuan and Jiang.

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)

Keywords

  • big data
  • cost-effectiveness analysis
  • pharmacoeconomics
  • real-world data
  • systematic review

Fingerprint

Dive into the research topics of 'Corrigendum: Big Data and Real-World Data Based Cost-Effectiveness Studies and Decision-Making Models: A Systematic Review and Analysis (Front. Pharmacol., (2021), 12, (700012), 10.3389/fphar.2021.700012)'. Together they form a unique fingerprint.

Cite this